Where is SurModics located?

SurModics is headquartered in Eden Prairie, United States. It is registered at Eden Prairie, Minnesota.

How many employees does SurModics have?

As of Dec 31, 2022, the latest employee count at SurModics is 270.

Is SurModics a funded company?

SurModics is a funded company, having raised a total of $***** in its 1st and only funding round.

What is the annual revenue of SurModics?

Annual revenue of SurModics is $126M as on Sep 30, 2024.

Where does SurModics rank among its competitors?

SurModics ranks 1st amongst 85 active competitors, of which 14 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was ProAxsis, which secured $299K in Jul, 2025.

Who are the top competitors of SurModics?

SurModics' top competitors include Accellix, Spear Bio and US BioTek Laboratories. Among them, ProAxsis secured the most recent funding round in July, 2025.

SurModics - 2026 Company Profile, Competitors & Financials

Company Details

Manufacturer of in-vitro diagnostic assays and reagents. The company is developing immunoassays, including ELISAs, and point-of-care devices for diagnostic applications. The company's products include antigens & antibodies, ELISA protein stabilizers, diluents & blockers, ELISA substrates, microarray slides, and TMB substrates.

Website: www.surmodics.com/
Email ID: *****@surmodics.com
Phone Number: +1 **********
Registered Address: Eden Prairie, Minnesota

Key Metrics

Founded Year

1979

Location

Eden Prairie, United States

Stage

Acquired

Ranked

1^st among 85 active competitors

Annual Revenue

$126M as on Sep 30, 2024

Employee Count

270 as on Dec 31, 2022

Investment & Acquisitions

Vetex Medical & 4 more

Similar Companies

Accellix & 97 more

Exit Details

Acquired by GTCR (May 29, 2024)

View SurModics' full profile

SurModics is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SURMODICS INC CIN: 924717 , United States, Active		$126M (As on Sep 30, 2024)	-	-
Surmodics, Inc. CIN: 411356149 , United States, Active	Dec 26, 999	-	291 (As on Dec 31, 2024)	-

SurModics got acquired by GTCR on May 29, 2024. It was facilitated by Kirkland & Ellis.

Click here to take a look at SurModics's acquisition in detail

SurModics has not raised any funding rounds yet.

SurModics' employee count trend

SurModics has 270 employees as of Dec 22. The total employee count is 14.0% more than what it was in Dec 21. Here is SurModics's employee count trend over the years:

Uncover SurModics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SurModics include Accellix, Spear Bio and US BioTek Laboratories. Here is the list of Top 10 competitors of SurModics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SurModics 1979, Eden Prairie (United States), Acquired	Manufacturer of in-vitro diagnostic assays and reagents	-	-	56/100
2nd	Accellix 2007, San Jose (United States), Acquired	Developer of immunotherapy-based assay delivery platform	$35.8M	Axcel, BioMerieux & 2 others	60/100
3rd	Spear Bio 2021, Boston (United States), Series A	Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers	$49M	Foresite Capital, Bio-Techne & 5 others	59/100
4th	US BioTek Laboratories 2008, Shoreline (United States), Acquired	Provider of enzyme-linked immunosorbent assay technology services	$19.5M	Capitala Group, Pike Street Capital	58/100
5th	Olink 2004, Uppsala (Sweden), Acquired	Provider of products and services for human protein biomarker research and development	-	Vitruvian Partners, Green Sands Equity & 4 others	51/100
6th	ProAxsis 2013, Belfast (United Kingdom), Acquired	Developer of diagnostic test for the detection of respiratory conditions	$2.79M	Northern Ireland Science, Qubis & 5 others	47/100
7th	Correlia Biosystems 2013, Berkeley (United States), Series A	Developer of immunoassay platforms to quantify proteins for proteomics and pharmaceutical applications	$10.9M	Neotribe, Cota Capital & 12 others	47/100
8th	RemedyBio 2017, Dublin (Ireland), Series A	Provider of personalised, cell based, autologous and anti-tumour therapy	$9.43M	Enterprise Ireland, EIC Fund & 3 others	46/100
9th	ET Healthcare 2008, Shanghai (China), Series D	Provider of an electrochemiluminescence analyzer	$15.5M	Sequoia Capital China, Kaiser Permanente & 9 others	44/100
10th	Presage Biosciences 2008, Seattle (United States), Series E	Translational oncology company pioneering drug development with its CIVO platform	$35M	Celgene, Takeda Ventures & 6 others	44/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on SurModics's competitors? Click here to see the top ones

SurModics has made 3 investments in companies including Nexeon MedSystems and Nexeon MedSystems. SurModics has also acquired 2 companies including Vetex Medical and NorMedix.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jul 06, 2021	Acquisition	Vetex Medical	2016	Galway (Ireland)
Aug 09, 2017	Investments	Nexeon MedSystems	2004	Lexington (United States)
Jan 11, 2016	Acquisition	NorMedix	2008	Plymouth (United States)